wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414632-F242D63E-3074-4EED-9E71-57511A812C87
Q33414632-F242D63E-3074-4EED-9E71-57511A812C87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414632-F242D63E-3074-4EED-9E71-57511A812C87
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors.
P2860
Q33414632-F242D63E-3074-4EED-9E71-57511A812C87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414632-F242D63E-3074-4EED-9E71-57511A812C87
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e52093b6d7da330aeb190a9be1dc362722d8f7d8
P2860
Targeting the HGF/Met signaling pathway in cancer therapy